|
NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
|
US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
|
KR100221066B1
(ko)
|
1989-10-13 |
1999-10-01 |
스튜어트 엘.왓트 |
에리트로포이에틴 유사체와 그를 포함하는 제약학적 조성물
|
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
US5856298A
(en)
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
|
CN1057534C
(zh)
|
1993-08-17 |
2000-10-18 |
柯瑞英-艾格公司 |
促红细胞生成素类似物
|
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
|
US5773569A
(en)
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
|
DE69534530T2
(de)
|
1994-08-12 |
2006-07-06 |
Immunomedics, Inc. |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
|
ES2297889T3
(es)
|
1997-07-14 |
2008-05-01 |
Bolder Biotechnology, Inc. |
Derivados de hormona de crecimiento y proteinas relacionadas.
|
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
PT986644E
(pt)
|
1997-07-23 |
2007-01-31 |
Roche Diagnostics Gmbh |
Preparação de eritropoietina por activação genética endógena com promotores virais
|
|
US6030086A
(en)
|
1998-03-02 |
2000-02-29 |
Becton, Dickinson And Company |
Flash tube reflector with arc guide
|
|
US6310078B1
(en)
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
|
US20050181482A1
(en)
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
|
DE69933216T2
(de)
|
1998-06-15 |
2007-09-20 |
GTC Biotherapeutics, Inc., Framingham |
Erythropoietin-analog-menschliches serum-albumin fusionsprotein
|
|
MEP42108A
(en)
|
1998-10-23 |
2011-02-10 |
Kiren Amgen Inc |
Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
|
|
AU774989B2
(en)
|
1998-10-23 |
2004-07-15 |
Amgen, Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
ATE481487T1
(de)
|
1998-11-27 |
2010-10-15 |
Ucb Sa |
Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
|
|
EP1006184A1
(en)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
|
|
EP1169352A4
(en)
|
1999-04-14 |
2005-05-04 |
Smithkline Beecham Corp |
ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
EP1226243A2
(en)
|
1999-10-22 |
2002-07-31 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules derived from rat brain and programmed cell death models
|
|
US20050202538A1
(en)
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
|
CA2391080A1
(en)
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Erythropoietin forms with improved properties
|
|
GB2375113B
(en)
|
2000-01-21 |
2004-10-20 |
Biovex Ltd |
A modified, oncolytic, non-laboratory HSV strain and its use in treating cancer
|
|
AUPQ599700A0
(en)
|
2000-03-03 |
2000-03-23 |
Super Internet Site System Pty Ltd |
On-line geographical directory
|
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
PT1274728E
(pt)
|
2000-04-21 |
2008-06-20 |
Amgen Inc |
Métodos e composições para a prevenção e tratamento de anemia
|
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
|
US7078376B1
(en)
|
2000-08-11 |
2006-07-18 |
Baxter Healthcare S.A. |
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
|
|
KR20030057529A
(ko)
|
2000-09-08 |
2003-07-04 |
그리폰 테라퓨틱스, 인코포레이티드 |
합성 적혈구생성 자극 단백질
|
|
US7271689B1
(en)
|
2000-11-22 |
2007-09-18 |
Fonar Corporation |
Magnet structure
|
|
EP1345628B1
(en)
|
2000-12-20 |
2011-04-13 |
F. Hoffmann-La Roche AG |
Conjugates of erythropoietin (epo) with polyethylene glycol (peg)
|
|
ME00502B
(me)
|
2001-01-05 |
2011-10-10 |
Amgen Fremont Inc |
Antitjela za insulinu sličan receptor faktora i rasta
|
|
CA2443373A1
(en)
|
2001-04-04 |
2002-10-31 |
Genodyssee |
New polynucleotides and polypeptides of the erythropoietin gene
|
|
DK1385882T3
(da)
|
2001-05-11 |
2008-02-11 |
Amgen Inc |
Peptider og relaterede molekyler, der binder til TALL-1
|
|
EP2295081B1
(en)
|
2001-06-26 |
2018-10-31 |
Amgen Inc. |
Antibodies to OPGL
|
|
US6900292B2
(en)
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
|
RS51829B
(sr)
|
2001-08-23 |
2012-02-29 |
Genmab A/S. |
Ljudska antitela specifična za interleukin 15 (il-15)
|
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
WO2003055526A2
(en)
|
2001-12-21 |
2003-07-10 |
Maxygen Aps |
Erythropoietin conjugates
|
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
SI1461359T1
(sl)
|
2002-01-18 |
2007-06-30 |
Pf Medicament |
Nova anti IGF-IR protitelesa in njihova uporaba
|
|
WO2003064664A1
(en)
|
2002-01-31 |
2003-08-07 |
Oxford Biomedica (Uk) Limited |
Physiologically regulated erythropoietin- exprressing vector for the treatment of anaemia
|
|
GB0202252D0
(en)
|
2002-01-31 |
2002-03-20 |
Oxford Biomedica Ltd |
Anemia
|
|
ATE363541T1
(de)
|
2002-03-26 |
2007-06-15 |
Lek Tovarna Farmacevtskih |
Verfahren für die herstellung eines gewünschten profils von erythropoietin glyko-isoformen
|
|
BRPI0308946B1
(pt)
|
2002-03-29 |
2016-08-30 |
Kumiai Chemical Industry Co |
ácido nucleico, proteína, vetor recombinante, bactéria, processos para cultivar planta que apresenta o referido ácido nucleico, para cultivar planta que apresenta a referida proteína, para seleção de célula transformante que apresenta o referido ácido nucleico e para selecionar célula transformante que apresenta a referida proteína
|
|
EP1572079A4
(en)
|
2002-03-29 |
2006-09-06 |
Centocor Inc |
MAMMAL-CDR MIMETIC BODIES, COMPOSITIONS, PROCESSES AND APPLICATION PURPOSES
|
|
US20040009902A1
(en)
|
2002-05-13 |
2004-01-15 |
Irving Boime |
CTP extended erythropoietin
|
|
EP1506286B1
(en)
|
2002-05-24 |
2014-03-19 |
Merck Sharp & Dohme Corp. |
Neutralizing human anti-igfr antibody
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US7241733B2
(en)
|
2002-06-28 |
2007-07-10 |
Centocor, Inc. |
Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
|
|
CA2490409A1
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
|
AU2003246486A1
(en)
|
2002-07-19 |
2004-02-09 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
|
TW200413406A
(en)
|
2002-08-26 |
2004-08-01 |
Kirin Brewery |
Peptides and drugs containing the same
|
|
KR101317045B1
(ko)
|
2002-09-06 |
2013-10-16 |
암젠 인코포레이티드 |
치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체
|
|
WO2005025606A1
(en)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
|
BR0314227A
(pt)
|
2002-09-11 |
2005-10-25 |
Fresenius Kabi De Gmbh |
Derivados de amido de hidroxialquila
|
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
|
US7396913B2
(en)
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
|
US20040071694A1
(en)
|
2002-10-14 |
2004-04-15 |
Devries Peter J. |
Erythropoietin receptor binding antibodies
|
|
WO2004034988A2
(en)
|
2002-10-16 |
2004-04-29 |
Amgen Inc. |
Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors
|
|
US6896666B2
(en)
*
|
2002-11-08 |
2005-05-24 |
Kochamba Family Trust |
Cutaneous injection delivery under suction
|
|
US20040091961A1
(en)
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
|
BR0317538A
(pt)
|
2002-12-20 |
2005-11-29 |
Amgen Inc |
Agente ligante, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, e, métodos de inibir a atividade de miostatina, de aumentar a massa muscular magra e a razão de massa muscular magra para gordura, de tratar uma doença de emaciação muscular e um distúrbio metabólico relacionado com miostatina em um indivìduo, de detectar e medir miostatina em uma amostra, e, de diagnosticar um distúrbio relacionado com miostatina em um indivìduo
|
|
JP2007528201A
(ja)
|
2003-03-14 |
2007-10-11 |
ファルマシア・コーポレーション |
癌治療のためのｉｇｆ−ｉ受容体に対する抗体
|
|
ES2383014T3
(es)
|
2003-04-02 |
2012-06-15 |
F. Hoffmann-La Roche Ag |
Anticuerpos contra el factor I de crecimiento similar a insulina y usos de los mismos
|
|
US7220410B2
(en)
|
2003-04-18 |
2007-05-22 |
Galaxy Biotech, Llc |
Monoclonal antibodies to hepatocyte growth factor
|
|
CA2524305C
(en)
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
EP1631336B1
(en)
|
2003-05-08 |
2010-02-17 |
Novo Nordisk A/S |
Pivotable injection needle unit
|
|
ATE428727T1
(de)
|
2003-05-12 |
2009-05-15 |
Affymax Inc |
Neue, an den erythropoietinrezeptor bindende peptide
|
|
AU2004238868B2
(en)
|
2003-05-12 |
2010-01-21 |
Affymax, Inc. |
Peptides that bind to the erythropoietin receptor
|
|
CN1820024B
(zh)
|
2003-05-12 |
2011-06-22 |
阿费麦克斯公司 |
新的聚(乙二醇)修饰的化合物及其用途
|
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
|
CA2527665A1
(en)
|
2003-05-30 |
2004-12-16 |
Centocor, Inc. |
Formation of novel erythropoietin conjugates using transglutaminase
|
|
WO2005001136A1
(en)
|
2003-06-04 |
2005-01-06 |
Irm Llc |
Methods and compositions for modulating erythropoietin expression
|
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
AR045056A1
(es)
|
2003-07-15 |
2005-10-12 |
Amgen Inc |
Anticuerpos anti-ngf humanos neutralizantes como inhibidores selectivos de la via de ngf
|
|
TWI476206B
(zh)
|
2003-07-18 |
2015-03-11 |
Amgen Inc |
對肝細胞生長因子具專一性之結合劑
|
|
US20050019914A1
(en)
|
2003-07-24 |
2005-01-27 |
Aventis Pharma Deutschland Gmbh |
Perfusion process for producing erythropoietin
|
|
GB0317511D0
(en)
|
2003-07-25 |
2003-08-27 |
Biovex Ltd |
Viral vectors
|
|
EP1663278A4
(en)
|
2003-08-28 |
2009-07-29 |
Biorexis Pharmaceutical Corp |
EPO MIMETIC PEPTIDES AND FUSION PROTEINS
|
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
|
EP1687452A4
(en)
|
2003-09-30 |
2008-08-06 |
Centocor Inc |
HUMAN HINGE-CORE MIMETICORPS, COMPOSITIONS, METHODS AND APPLICATIONS THEREOF
|
|
BRPI0416603A
(pt)
|
2003-11-07 |
2007-01-30 |
Immunex Corp |
anticorpo que se liga ao receptor interleucina-4 (il-4) humano
|
|
TW200526684A
(en)
|
2003-11-21 |
2005-08-16 |
Schering Corp |
Anti-IGFR1 antibody therapeutic combinations
|
|
EP1694347B1
(en)
|
2003-11-24 |
2013-11-20 |
BioGeneriX AG |
Glycopegylated erythropoietin
|
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
WO2005058967A2
(en)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
|
|
EP1548031A1
(en)
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Nature-identical erythropoietin
|
|
RU2370276C2
(ru)
|
2003-12-31 |
2009-10-20 |
Мерк Патент Гмбх |
Fc-ЭРИТРОПОЭТИН СЛИТЫЙ БЕЛОК С УЛУЧШЕННОЙ ФАРМАКОКИНЕТИКОЙ
|
|
WO2005065239A2
(en)
|
2003-12-31 |
2005-07-21 |
Centocor, Inc. |
Novel recombinant proteins with n-terminal free thiol
|
|
US7423139B2
(en)
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
|
WO2005070451A1
(en)
|
2004-01-22 |
2005-08-04 |
Zafena Aktiebolag |
Pharmaceutical composition comprising non-glycosylated erythropoietin
|
|
WO2005084711A1
(en)
|
2004-03-02 |
2005-09-15 |
Chengdu Institute Of Biological Products |
A pegylated recombinant erythropoietin that has in vivo activity
|
|
WO2005092369A2
(en)
|
2004-03-11 |
2005-10-06 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyethyl starch and erythropoietin
|
|
WO2005094879A2
(en)
|
2004-03-23 |
2005-10-13 |
Amgen, Inc. |
Monoclonal antibodies specific for human ox40l (cd 134l)
|
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
|
CA2563874A1
(en)
|
2004-04-23 |
2005-11-03 |
Cambridge Antibody Technology Limited |
Erythropoietin protein variants
|
|
WO2006002646A2
(en)
|
2004-07-07 |
2006-01-12 |
H. Lundbeck A/S |
Novel carbamylated epo and method for its production
|
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
US20060073563A1
(en)
|
2004-09-02 |
2006-04-06 |
Xencor, Inc. |
Erythropoietin derivatives with altered immunogenicity
|
|
CA2586915A1
(en)
|
2004-11-10 |
2006-05-18 |
Aplagen Gmbh |
Molecules which promote hematopoiesis
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
US7906625B2
(en)
|
2005-01-24 |
2011-03-15 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
CA2612449A1
(en)
|
2005-06-17 |
2006-12-28 |
Imclone Systems Incorporated |
Receptor antagonists for treatment of metastatic bone cancer
|
|
WO2007000328A1
(en)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
|
EP2397498A3
(en)
|
2005-07-18 |
2013-11-27 |
Amgen, Inc |
Human anti-B7RP1 neutralizing antibodies
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
|
GB0603683D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之ｃ-ｋｉｔ抗體
|
|
US7851438B2
(en)
|
2006-05-19 |
2010-12-14 |
GlycoFi, Incorporated |
Erythropoietin compositions
|
|
US7789857B2
(en)
*
|
2006-08-23 |
2010-09-07 |
Medtronic Minimed, Inc. |
Infusion medium delivery system, device and method with needle inserter and needle inserter device and method
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
US20100040610A1
(en)
|
2006-11-07 |
2010-02-18 |
Ayesha Sitlani |
Antagonists of pcsk9
|
|
WO2008057459A2
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
WO2008057458A2
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
US20100040611A1
(en)
|
2006-11-07 |
2010-02-18 |
Sparrow Carl P |
Antagonists of pcsk9
|
|
JP5059119B2
(ja)
|
2006-12-14 |
2012-10-24 |
シェーリング コーポレイション |
操作された抗ｔｓｌｐ抗体
|
|
EA200901376A1
(ru)
|
2007-04-13 |
2010-12-30 |
Новартис Аг |
Молекулы и способы модуляции пропротеинконвертазы субтилизинового/кексинового типа 9(pcsk9)
|
|
CN102027012A
(zh)
|
2007-06-20 |
2011-04-20 |
Irm责任有限公司 |
用于治疗变应性疾病的方法和组合物
|
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
|
NZ584902A
(en)
|
2007-10-26 |
2012-03-30 |
Schering Corp |
Anti-pcsk9 and methods for treating lipid and cholesterol disorders
|
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
|
TWI516501B
(zh)
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Ｐｃｓｋ９拮抗劑類
|
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
|
US20120219558A1
(en)
|
2009-09-25 |
2012-08-30 |
Yan Ni |
Antagonists of pcsk9
|
|
IN2012DN03824A
(https=)
|
2009-10-30 |
2015-08-28 |
Merck Sharp & Dohme |
|
|
CN102596249A
(zh)
|
2009-10-30 |
2012-07-18 |
默沙东公司 |
Ax1和ax189 pcsk9拮抗剂和变体
|
|
AR079336A1
(es)
|
2009-12-11 |
2012-01-18 |
Irm Llc |
Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
|
|
JP5932670B2
(ja)
|
2010-03-11 |
2016-06-08 |
ライナット ニューロサイエンス コーポレイション |
ｐＨ依存性の抗原結合を有する抗体
|
|
WO2012054438A1
(en)
|
2010-10-22 |
2012-04-26 |
Schering Corporation |
Anti-pcsk9
|
|
CN103261230A
(zh)
|
2010-12-22 |
2013-08-21 |
霍夫曼-拉罗奇有限公司 |
抗pcsk9抗体及使用方法
|
|
SG192117A1
(en)
|
2011-01-28 |
2013-08-30 |
Sanofi Sa |
Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
|
|
WO2012109530A1
(en)
|
2011-02-11 |
2012-08-16 |
Irm Llc |
Pcsk9 antagonists
|
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
|
CN104619365B
(zh)
|
2012-09-28 |
2017-04-19 |
泰尔茂株式会社 |
穿刺装置以及药液给予装置
|
|
US20160067347A1
(en)
|
2012-12-20 |
2016-03-10 |
Amgen Inc. |
Apj receptor agonists and uses thereof
|
|
US20140274874A1
(en)
|
2013-03-14 |
2014-09-18 |
Amgen Inc. |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
|
EP2970407B1
(en)
|
2013-03-14 |
2023-11-15 |
Amgen Inc. |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
|
CN108704191B
(zh)
*
|
2013-05-31 |
2021-02-05 |
西兰制药公司 |
具有可插入式预填充筒的流体输送装置
|
|
AU2014308659B2
(en)
*
|
2013-08-23 |
2018-11-01 |
Unl Holdings Llc |
Integrated pierceable seal fluid pathway connection and drug containers for drug delivery pumps
|
|
EP3134150B1
(en)
|
2014-04-24 |
2021-02-17 |
Becton, Dickinson and Company |
Fluid infusion device
|
|
JP6713467B2
(ja)
|
2014-09-29 |
2020-06-24 |
ユーエヌエル ホールディングス エルエルシーＵＮＬ Ｈｏｌｄｉｎｇｓ ＬＬＣ |
薬剤送達ポンプの為の剛性針挿入機構
|
|
EP4140520A1
(en)
*
|
2015-02-10 |
2023-03-01 |
Amgen Inc. |
Rotationally biased insertion mechanism for a drug delivery pump
|
|
US10080837B2
(en)
*
|
2015-07-07 |
2018-09-25 |
Flextronics Ap, Llc. |
Sterile patch pump
|